Interdigitating Dendritic Cell Sarcoma

Interdigitating dendritic cell sarcoma (IDCS) is an extremely rare dendritic cell tumor with slightly more than 100 cases reported in the English literature. This report discusses a case of localized IDCS involving cervical lymph nodes and provides a literature review of clinicopathologic aspects and treatment outcomes.

Target Audience

This activity has been designated to meet the educational needs of physicians and nurses involved in the management of patients with cancer.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Evaluate the patient demographics, clinicopathologic features, and therapeutic outcomes of documented IDCS cases
  • Discuss challenges in the accurate pathologic diagnosis, staging, and treatment of patients with IDCS
Additional information
Supporters: 

No commercial support was received for this article.

Course summary
Available credit: 
  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Physician
Course opens: 
02/18/2015
Course expires: 
02/18/2016
Cost:
$0.00
Venkata Pokuri, MD
Division of Medical Oncology
Roswell Park Cancer Institute
Buffalo, New York		Mihai Merzianu, MD
Department of Pathology
Roswell Park Cancer Institute
Buffalo, New York
Shipra Gandhi, MD
Department of Medicine
State University of New York
Buffalo, New York

Junaid Baqai, MD
Department of Pathology
Roswell Park Cancer Institute
Buffalo, New York

Thom Loree, MD, FACS
Department of Head & Neck and Plastic & Reconstructive Surgery
Erie County Medical Center
Buffalo, New York		Seema Bhat, MD
Division of Medical Oncology
Roswell Park Cancer Institute
Buffalo, New York

 

Available Credit

  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Physician

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To access this activity, users will need:

  • A device with an Internet connection
  • Adobe Reader or other PDF reader software for article and certificate viewing/printing